Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
Ch FottnerM M Weber

Abstract

Clinically silent adrenocortical adenomas are the most frequent abnormalities in the adrenal gland. In contrast, adrenocortical carcinoma is a rare tumor with an extremely poor prognosis. The factors responsible for the frequent occurrence of benign adrenocortical tumors on one hand and the rare malignant transformation on the other are not known. Several genetic alterations such as loss of imprinting or loss of heterozygosity of the 11p15 gene locus causing a strong IGF-II overexpression have been demonstrated in the majority of adrenocortical carcinomas. In addition to IGF-II overexpression, increased levels of the IGF-I-receptor and IGFBP-2 have been found in advanced human adrenocortical carcinomas, suggesting an important role for the IGF-system in adrenocortical carcinogenesis. IGFs are potent mitogens regulating growth and apoptosis through interaction with the IGF-I-receptor, and overexpression of the human IGF-I-receptor promotes ligand-dependent neoplastic transformation in a variety of different cell systems. It is evident, therefore, that high levels of IGF-II in combination with overexpression of the IGF-I-receptor can provide a significant growth advantage for adrenocortical carcinoma cells and thus contribute to ...Continue Reading

Citations

Oct 16, 2007·Reviews in Endocrine & Metabolic Disorders·Ferdous M Barlaskar, Gary D Hammer
Sep 19, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marco VolanteMauro Papotti
Aug 12, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jason B DouglasRachael Z Stolzenberg-Solomon
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas J GiordanoGary Hammer
Mar 6, 2009·Veterinary Pathology·M BielinskaD B Wilson
Mar 13, 2012·The Journal of Endocrinology·Constanze HantelFelix Beuschlein
May 17, 2014·Annals of Surgical Oncology·Dhaval PatelElectron Kebebew
Sep 13, 2008·Journal of Endocrinological Investigation·C ScaroniF Mantero
Mar 31, 2011·Expert Opinion on Investigational Drugs·Elizabeth Buck, Mark Mulvihill
Oct 25, 2011·Molecular and Cellular Endocrinology·Tamaya Castro Ribeiro, Ana Claudia Latronico
Dec 1, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Thomas J Giordano
Dec 19, 2015·Molecular and Cellular Endocrinology·Kaitlin J BashamGary D Hammer
Jul 20, 2007·Pediatric Blood & Cancer·Kristin DawczynskiFelix Zintl
Dec 4, 2009·International Journal of Cancer. Journal International Du Cancer·Yu-Wei ChengFrancis Barany
Apr 12, 2011·Journal of Surgical Oncology·Frederick L BaehnerMichael T Barrett
Mar 21, 2016·Molecular and Cellular Endocrinology·Felix BeuschleinConstanze Hantel
Jul 18, 2006·Biochimica Et Biophysica Acta·Raushan T Kurmasheva, Peter J Houghton
Aug 29, 2012·Journal of Oncology·Roberta MalaguarneraAntonino Belfiore
Mar 24, 2015·Frontiers in Endocrinology·Marjut PihlajokiDavid B Wilson
Apr 30, 2014·Frontiers in Endocrinology·Andreas HoeflichJulia Brenmoehl
May 18, 2016·Endocrine-related Cancer·Régia Caroline Peixoto LiraCarlos Alberto Scrideli
Sep 12, 2014·F1000Research·Joanna MatrozovaSabina Zacharieva
Sep 12, 2014·F1000Research·Joanna MatrozovaSabina Zacharieva
Jul 3, 2018·Minerva endocrinologica·Barbara AltieriAntongiulio Faggiano
Aug 17, 2006·The Journal of Clinical Endocrinology and Metabolism·Peter M van KoetsveldLeo J Hofland
Mar 23, 2006·The Journal of Clinical Endocrinology and Metabolism·Bruno Allolio, Martin Fassnacht
Mar 16, 2018·Journal of Endocrinological Investigation·C T BahadirH Atmaca
May 30, 2006·Molecular Cancer Therapeutics·Hong ZhangFrancis Burrows

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis